Mark Cuban Enters Convoluted PBM Market, Promises Lower Prescription Drug Prices
Two new groups have entered the pharmacy benefit manager (PBM) market: Mark Cuban and a coalition of employers. The Mark [...]
Register Now for Upcoming October Webinar on RWE in Regulatory Filings
Flatiron Health will hold a webinar detailing how real world evidence (RWE) can be used in regulatory findings. The webinar [...]
EURIPID Survey Shines Spotlight on Drug Price Transparency and Confidential Payer-Pharma Agreements
A recent article, published in Health Policy, highlights the use of confidential managed-entry agreements (MEAs) between payers and pharma throughout [...]
FDA Directors Discuss EUAs, Transparency, and COVID-19
In a recent meeting, Food and Drug Administration directors discussed how emergency use authorizations (EUAs) affected the response to the [...]
Part 2 of AmerisourceBergen Podcast on Insulin Biosimilars Now Available
Part two of AmerisourceBergen’s podcast series on insulin biosimilars is now available. This episode features guidance for pharmacies awaiting updated [...]
FDA Releases Draft Guidance on RWD in Pharma Submissions
The Food and Drug Administration (FDA) has released its draft guidance on real world data (RWD). The guidance is intended [...]
CMMI Director Discusses Aduhelm Coverage
Center for Medicare and Medicaid Innovation (CMMI) Director Elizabeth Fowler recently discussed Biogen’s Aduhelm drug. She noted that Congress first needs [...]
Data Expert Discusses 9 RWE Applications in Healthcare and Pharma R&D
Vice President of Business Development & Real World Evidence (RWE) at ArborMetrix Benjamin Echeazu discusses the growing use of RWE [...]
AMCP Announces New Series on Medical Benefits Medication Management
The Academy of Managed Care Pharmacy (AMCP) is offering a self-paced program detailing the intricacies of medication management. The program [...]
American Drug Market Is a Pharma Cash Cow
A recent report considers the prescription drug prices of 20 top-selling drugs—both in the United States and worldwide. The trend [...]
Short Webinar Presents Solution to Improve Medication Adherence in Patients With Chronic Disease
HealthPrize has released a short six-minute webinar detailing how it has successfully addressed medication adherence challenges in patients suffering from [...]
Infographic Details Solutions to Cell and Gene Therapy Manufacturing Challenges
A newly published infographic, provided by Catalent, highlights some of the challenges associated with cell and gene therapies—and how to [...]
PRMA Consulting Senior Advisor Discusses the Four Pillars of Market Access and New Pharma Trends
Senior Advisor, Asia-Pacific at PRMA Consulting Jeff Weisel shared an update to his previous article detailing the four strategic pillars [...]
New Book on Historic and Future Pharma Trends Now Available
A recently published book authored by Mickey C. Smith, PhD details the multi-faceted issues facing pharma and healthcare. Francis B. [...]
ICER’s Value Assessments Inform Pricing Decisions
Although new technologies have brought about novel therapies for previously unaddressed diseases, setting prices for these sometimes life-saving treatments remains [...]
Medicare Price Negotiation Idea Gaining Ground
Allowing Medicare to negotiate drug prices with pharma may soon become policy. A growing number of legislators have publicly expressed [...]
Pharma Overhaul Would Reduce Drug Costs While Supporting Innovation
A recent article discusses the impact of legislation intended to lower drug prices on the pharmaceutical industry, such as price [...]
Aetion eBook Highlights the Impact of RWE in Successful Drug Approvals Ahead of FDA Framework
Aetion has published an eBook detailing how real world data (RWD) and real world evidence (RWE) can impact drug approvals [...]
Syneos Health Executive VP and Data Expert Discusses RWE and Aetion Collaboration
Executive Vice President of Real World Evidence (RWE) and Late Phase at Syneos Health Javier Jimenez discusses major industry trends [...]
Podcast on Preparing for Insulin Biosimilar Approval Now Available
AmerisourceBergen has released part two of a podcast detailing how insulin biosimilars will affect pharmacies and patients. “In part two [...]
Cytel Statistician Discusses the Importance of Traceability in R&D Data Handling
Cytel’s Angelo Tinazzi discusses data traceability in a recent blog post. An expert in statistical programming and clinical data analysis, [...]
Major Corporations Weigh In As Drug Pricing Debate Continues
Major American corporations are split in half as the drug pricing debate continues. One camp, led by the U.S. Chamber [...]
Prescription Drug Pricing Reform Could Mean Discounts on AAP Drugs Pending Clinical Proof
As multidisciplinary stakeholders consider how to reform the prescription drug pricing structure, one recent proposal is gaining traction. Drugs pushed [...]
OPEN Health Announces New CEO of Communications
OPEN Health has announced that Margot Hannah will take on the role of Chief Executive Officer of OPEN Health Communications. [...]
MMIT and Evaluate Acquire Panalgo to Streamline RWE and Ultimately Improve Patient Outcomes
Managed Markets Insight & Technology (MMIT) and Evaluate announced their acquisition of healthcare analytics company Panalgo. This acquisition will streamline [...]